Equities

Recordati Industria Chimica e Farmaceutica SpA

Recordati Industria Chimica e Farmaceutica SpA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)52.78
  • Today's Change-0.08 / -0.15%
  • Shares traded121.23k
  • 1 Year change+36.03%
  • Beta0.2729
Data delayed at least 15 minutes, as of Mar 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • REC:MIL price reached a new 52-week high of 53.34 at 15:33 BST

Key statistics

On Thursday, Recordati Industria Chimica e Farmaceutica SpA (REC:MIL) closed at 52.78, -1.12% below its 52-week high of 53.38, set on Mar 13, 2024.
52-week range
Today
37.78Mar 15 202353.38Mar 13 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open53.14
High53.16
Low52.56
Bid52.52
Offer53.00
Previous close52.78
Average volume159.47k
Shares outstanding209.13m
Free float100.71m
P/E (TTM)29.10
Market cap11.05bn EUR
EPS (TTM)1.82
EUR
Annual div (ADY)1.17
EUR
Annual div yield (ADY)2.21%
Div ex-dateNov 20 2023
Div pay-dateNov 22 2023
Data delayed at least 15 minutes, as of Mar 14 2024.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.